Next Article in Journal
Beta 2 Adrenergic Receptor Antagonist Propranolol and Opioidergic Receptor Antagonist Naltrexone Produce Synergistic Effects on Breast Cancer Growth Prevention by Acting on Cancer Cells and Immune Environment in a Preclinical Model of Breast Cancer
Next Article in Special Issue
EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs)
Previous Article in Journal
Heat Shock Protein 27, a Novel Downstream Target of Collagen Type XI alpha 1, Synergizes with Fatty Acid Oxidation to Confer Cisplatin Resistance in Ovarian Cancer Cells
Previous Article in Special Issue
Octreotide and Pasireotide Combination Treatment in Somatotroph Tumor Cells: Predominant Role of SST2 in Mediating Ligand Effects
 
 
Article

Article Versions Notes

Cancers 2021, 13(19), 4857; https://doi.org/10.3390/cancers13194857
Action Date Notes Link
article xml file uploaded 28 September 2021 13:21 CEST Original file -
article xml uploaded. 28 September 2021 13:21 CEST Update https://www.mdpi.com/2072-6694/13/19/4857/xml
article pdf uploaded. 28 September 2021 13:21 CEST Version of Record https://www.mdpi.com/2072-6694/13/19/4857/pdf
article html file updated 28 September 2021 13:23 CEST Original file -
article html file updated 30 July 2022 08:09 CEST Update https://www.mdpi.com/2072-6694/13/19/4857/html
Back to TopTop